Furthermore, it was shown that inhibiting RANKL using recombinant mouse OPG (Amgen) or via vector overexpression [21] in a mouse model of T2D led to the improvement of both hepatic insulin resistance and serum glucose concentrations [22,23]. The gene discussed is TNFRSF11B; the disease is type 2 diabetes mellitus.